Solid Biosciences Inc (NASDAQ: SLDB) kicked off on Friday, up 5.38% from the previous trading day, before settling in for the closing price of $4.46. Over the past 52 weeks, SLDB has traded in a range of $2.41-$7.37.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 41.25%. While this was happening, its average annual earnings per share was recorded 31.21%. With a float of $58.92 million, this company’s outstanding shares have now reached $77.88 million.
Solid Biosciences Inc (SLDB) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Solid Biosciences Inc is 24.38%, while institutional ownership is 82.77%. The most recent insider transaction that took place on Nov 10 ’25, was worth 13,505. In this transaction Director of this company sold 3,278 shares at a rate of $4.12, taking the stock ownership to the 95,412 shares. Before that another transaction happened on Oct 20 ’25, when Company’s Chief Medical Officer sold 2,895 for $5.96, making the entire transaction worth $17,254. This insider now owns 33,819 shares in total.
Solid Biosciences Inc (SLDB) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1 earnings per share (EPS), lower than consensus estimate (set at -0.78) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.41% during the next five years compared to 41.25% growth over the previous five years of trading.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Take a look at Solid Biosciences Inc’s (SLDB) current performance indicators. Last quarter, stock had a quick ratio of 6.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.49, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.04 in one year’s time.
Technical Analysis of Solid Biosciences Inc (SLDB)
The latest stats from [Solid Biosciences Inc, SLDB] show that its last 5-days average volume of 1.22 million was inferior to 1.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.18%.
During the past 100 days, Solid Biosciences Inc’s (SLDB) raw stochastic average was set at 25.42%, which indicates a significant decrease from 76.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.45 in the past 14 days, which was higher than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.38, while its 200-day Moving Average is $4.85. Now, the first resistance to watch is $4.87. This is followed by the second major resistance level at $5.04. The third major resistance level sits at $5.25. If the price goes on to break the first support level at $4.49, it is likely to go to the next support level at $4.28. Assuming the price breaks the second support level, the third support level stands at $4.11.
Solid Biosciences Inc (NASDAQ: SLDB) Key Stats
The company with the Market Capitalisation of 366.18 million has total of 77,910K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -124,700 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -45,780 K.
